AVILEX PHARMA ApS
Core data
Name | AVILEX PHARMA ApS |
Address | Jagtvej 162, 2100, København Ø |
Founded | Dec 27, 2012 |
| 4 / 1.84Dec 2025 | |
Locations (P-units) | 1View locations |
Website | http://www.avilexpharma.com/ |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Name | AVILEX PHARMA ApS |
Address | Jagtvej 162, 2100, København Ø |
Founded | Dec 27, 2012 |
| 4 / 1.84Dec 2025 |
Locations (P-units) | 1View locations |
Website | http://www.avilexpharma.com/ |
Branch | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Keep track of AVILEX PHARMA ApS
Description
The company's activities comprise to the development of novel drug candidates for the treatment of stroke and other neurodegenerative conditions, as well as any activity related thereto as determined by the Board of Directors.
Financials
| Reporting period | 2025DKK | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating profit | -4,240,000 | ||||||||
| Profit before tax | -5,820,000 | ||||||||
| Net income | -4,530,000 | ||||||||
| Total assets | 18,391,000 | ||||||||
| Equity | -10,797,000 | ||||||||
| Avg. employees | 2 | ||||||||
2017–2025 Unlock financial history | |||||||||
Datapublica Risk Score
What goes into the assessment
Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details
Standard: Score and risk bandPro: Also a detailed explanation of the factors
Contact
No contact details have been registered for this company.
Gazelle
Loading gazelle status…
Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.
Founders
| Founder | Registered as founder | Current roles | Ownership |
|---|---|---|---|
| Anders Bach | Registered as founderDec 27, 2012 | Current roles — | Ownership 10–14.99 %Indirect via Anders Bach ApS |
People
| Person | Roles | Titles |
|---|---|---|
| Camilla Petrycer Hansen | Roles Board | TitlesBESTYRELSESMEDLEM |
| Kristian Strømgaard | Roles BoardManagement | TitlesBESTYRELSESMEDLEM • DIREKTØR |
Auditor
| Audit firm | Auditor | Role | From |
|---|---|---|---|
| EY Godkendt Revisionspartnerselskab | AuditorRasmus Bloch Jespersen | RoleState Authorised Public Accountant | FromJul 21, 2026 |
Legal owners
| Owner | Ownership | Voting rights | From |
|---|---|---|---|
| Ownership50–66.66 % | Voting rights50 % | FromSep 23, 2022 | |
| Ownership20–24.99 % | Voting rights20 % | FromJan 11, 2019 | |
| Ownership10–14.99 % | Voting rights10 % | FromJan 11, 2019 | |
| Ownership5–9.99 % | Voting rights5 % | FromJan 11, 2019 |
Ultimate owners
| Name | Ownership through | Calculated ownership |
|---|---|---|
| NOVO NORDISK FONDEN | Ownership through | 50–66.66 % |
| Kristian Strømgaard | Ownership through | 20–24.99 % |
| Anders Bach | Ownership through | 10–14.99 % |
| Mikael Søndergaard Thomsen | Ownership through | 5–9.99 % |